Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. More Details
Excellent balance sheet and fair value.
Share Price & News
How has Escalon Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ESMC's share price has been volatile over the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: ESMC underperformed the US Medical Equipment industry which returned 14.6% over the past year.
Return vs Market: ESMC underperformed the US Market which returned 12.7% over the past year.
Price Volatility Vs. Market
How volatile is Escalon Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Escalon Medical undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ESMC ($0.14) is trading below our estimate of fair value ($0.27)
Significantly Below Fair Value: ESMC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ESMC is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: ESMC is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ESMC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ESMC is good value based on its PB Ratio (0.8x) compared to the US Medical Equipment industry average (3.7x).
How is Escalon Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Escalon Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Escalon Medical is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Escalon Medical's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has Escalon Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ESMC is currently unprofitable.
Growing Profit Margin: ESMC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ESMC is unprofitable, but has reduced losses over the past 5 years at a rate of 43.3% per year.
Accelerating Growth: Unable to compare ESMC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ESMC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).
Return on Equity
High ROE: ESMC has a negative Return on Equity (-9.51%), as it is currently unprofitable.
How is Escalon Medical's financial position?
Financial Position Analysis
Short Term Liabilities: ESMC's short term assets ($4.1M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: ESMC's short term assets ($4.1M) exceed its long term liabilities ($975.5K).
Debt to Equity History and Analysis
Debt Level: ESMC's debt to equity ratio (11%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if ESMC's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable ESMC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: ESMC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 28.9% per year.
What is Escalon Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ESMC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ESMC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ESMC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ESMC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ESMC's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Rich DePiano (54 yo)
Mr. Richard J. DePiano, Jr., also known as Rich, has been the Chief Executive Officer, President and General Counsel of Escalon Medical Corp. since September 25, 2013, January 1, 2008 and December 28, 2006 ...
CEO Compensation Analysis
Compensation vs Market: Rich's total compensation ($USD194.22K) is below average for companies of similar size in the US market ($USD601.89K).
Compensation vs Earnings: Rich's compensation has been consistent with company performance over the past year.
|Independent Director||17.08yrs||US$22.14k||0% |
|Independent Director||2.58yrs||no data||no data|
|Independent Director||4.92yrs||no data||0.0034% |
|Independent Director||2.58yrs||no data||no data|
Experienced Board: ESMC's board of directors are considered experienced (4.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Escalon Medical Corp.'s company bio, employee growth, exchange listings and data sources
- Name: Escalon Medical Corp.
- Ticker: ESMC
- Exchange: OTCPK
- Founded: 1987
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$1.038m
- Shares outstanding: 7.42m
- Website: https://www.escalonmedical.com
Number of Employees
- Escalon Medical Corp.
- Building 100
- 435 Devon Park Drive
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ESMC||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Sep 1992|
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which pro ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/23 05:58|
|End of Day Share Price||2020/09/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.